- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Experimental Diabetes Research
Volume 2010 (2010), Article ID 176361, 11 pages
The Role of Rho Kinase in Sex-Dependent Vascular Dysfunction in Type 1 Diabetes
1The Department of Veterans Affairs Iowa City Health Care System, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, IA 52246, USA
2Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, IA 52242, USA
3Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, IA 52242, USA
Received 17 September 2009; Revised 1 December 2009; Accepted 14 January 2010
Academic Editor: Subrata K. Chakrabarti
Copyright © 2010 Daniel W. Nuno and Kathryn G. Lamping. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [7 citations]
The following is the list of published articles that have cited the current article.
- L. Yao, S. Chandra, H. A. Toque, A. Bhatta, M. Rojas, R. B. Caldwell, and R. W. Caldwell, “Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout,” Cardiovascular Research, vol. 97, no. 3, pp. 509–519, 2012.
- Daniel W. Nuno, Sarah K. England, and Kathryn G. Lamping, “RhoA localization with caveolin-1 regulates vascular contractions to serotonin,” American Journal of Physiology - Regulatory Integrative and Comparative Physiology, vol. 303, no. 9, pp. R959–R967, 2012.
- Peter M. Nelson, Jeremy S. Harrod, and Kathryn G. Lamping, “5HT(2A) and 5HT(2B) Receptors Contribute to Serotonin-Induced Vascular Dysfunction in Diabetes,” Experimental Diabetes Research, 2012.
- Xiao Miao, Yuehui Wang, Yonggang Wang, Jian Sun, Weixia Sun, Yi Tan, Lu Cai, Yang Zheng, Guanfang Su, and Quan Liu, “Zinc protects against diabetes-induced pathogenic changes in the aorta: Roles of metallothionein and nuclear factor (erythroid-derived 2)-like 2,” Cardiovascular Diabetology, vol. 12, no. 1, 2013.
- John P. Headrick, Chanchal Chandramouli, Melissa E. Reichelt, Kimberley M. Mellor, James R. Bell, and Lea M. D. Delbridge, “Sex, sex steroids, and diabetic cardiomyopathy: making the case for experimental focus,” American Journal Of Physiology-Heart And Circulatory Physiology, vol. 305, no. 6, pp. H779–H792, 2013.
- Gervaise Loirand, “Rho Kinases in Health and Disease: From Basic Science to Translational Research,” Pharmacological Reviews, vol. 67, no. 4, pp. 1074–1095, 2015.
- Shun Watanabe, Takayuki Matsumoto, Makoto Ando, Shota Kobayashi, Maika Iguchi, Kumiko Taguchi, and Tsuneo Kobayashi, “Effect of Long-Term Diabetes on Serotonin-Mediated Contraction in Carotid Arteries from Streptozotocin-Induced Diabetic Male and Female Rats,” Biological and Pharmaceutical Bulletin, vol. 39, no. 10, pp. 1723–1727, 2016.